Search Results - "Martínez Trufero, J."

SEOM clinical guidelines for the treatment of head and neck cancer (2020) by Mesia, R., Iglesias, L., Lambea, J., Martínez-Trufero, J., Soria, A., Taberna, M., Trigo, J., Chaves, M., García-Castaño, A., Cruz, J.

“…Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain…”
Get full text

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study by Martínez-Trufero, J., Lozano Borbalas, A., Pajares Bernad, I., Taberna Sanz, M., Ortega Izquierdo, E., Cirauqui Cirauqui, B., Rubió-Casadevall, J., Plana Serrahima, M., Ponce Ortega, J.M., Planas Toledano, I., Caballero, J., Marruecos Querol, J., Iglesias Docampo, L., Lambea Sorrosal, J., Adansa, J. C., Mesía Nin, R.

“…Background Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb…”
Get full text

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location by Seijas-Tamayo, R., Fernández-Mateos, J., Adansa Klain, J. C., Mesía, R., Pastor Borgoñón, M., Pérez-Ruiz, E., Vázquez Fernández, S., Salvador Coloma, C., Rueda Domínguez, A., Taberna, M., Martínez-Trufero, J., Bonfill Abella, T., Vázquez Estévez, S., Pollán, M., del Barco Morillo, E., Cruz-Hernández, J. J.

“…Purpose Head and neck cancer is a highly heterogeneous disease comprising a large number of tumors located in the cervicofacial area. This study aimed to…”
Get full text

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC) by Pazo-Cid, R. A., Lanzuela, M., Esquerdo, G., Pérez-Gracia, J. L., Antón, A., Amigo, G., Trufero, J. Martínez, García-Otín, A. L., Martín-Duque, P.

“…Angiogenesis is a cornerstone in the process of hepatocarcinogenesis. In the sorafenib era, other antiangiogenic targeted drugs, such as monoclonal antibodies…”
Get full text

Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study by Fuster, D, Ayuso, J R, Poveda, A, Cubedo, R, Casado, A, Martínez-Trufero, J, López-Pousa, A, Del Muro, X G, Lomeña, F, Maurel, J, Pons, F

“…The aim of this study was to evaluate the utility of positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) in monitoring response in refractory…”
Get full text

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer by Hitt, R., Grau, J.J., López-Pousa, A., Berrocal, A., García-Girón, C., Irigoyen, A., Sastre, J., Martínez-Trufero, J., Brandariz Castelo, J.A., Verger, E., Cruz-Hernández, J.J., Almodóvar, C., Cortés-Funes, H., Escobar, Y., Fonseca-Sánchez, E., Galcerán, J.C., Guix, M., Isla-Casado, D., Jara-Sánchez, C., Leitão-Silva, M.R., Mel-Lorenzo, J.R., Pastor-Borgoñón, M., Pastor-Gaitán, P., Rodríguez-Jaráiz, A., Millán, J.M., Satrustegui-Galdona, J., Moreno, M., Estefanía, E., Santiago, E., García, J.J.

“…Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients with unresectable, nonmetastatic locoregionally advanced squamous-cell carcinoma of…”
Get full text

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS) by Martin-Broto, J., Redondo, A., Valverde, C., Vaz, M.A., Mora, J., Garcia del Muro, X., Gutierrez, A., Tous, C., Carnero, A., Marcilla, D., Carranza, A., Sancho, P., Martinez-Trufero, J., Diaz-Beveridge, R., Cruz, J., Encinas, V., Taron, M., Moura, D.S., Luna, P., Hindi, N., Lopez-Pousa, A.

“…Patients with relapsed unresectable osteosarcoma represents an unmet need, so active and safe systemic treatments are required. Fas cell surface death receptor…”
Get full text

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial by Hitt, R., Iglesias, L., López-Pousa, A., Berrocal-Jaime, A., Grau, J. J., García-Girón, C., Martínez-Trufero, J., Guix, M., Lambea-Sorrosal, J., del Barco-Morillo, E., León-Vintró, X., Cunquero-Tomas, A. J., Baste, N., Ocaña, A., Cruz-Hernández, J. J.

“…Background Our previous phase-3 study (TTCC 2503) failed to show overall survival advantage of 2 induction chemotherapy (IC) regimens followed by standard…”
Get full text

Phase I II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study by LOPEZ-POUSA, A, LOSA, R, MARTINEZ-TRUFERO, J, ESTEBAN, E, BUESA, J. M, MARTIN, J, MAUREL, J, FRA, J, SIERRA, M, CASADO, A, GARCIA DEL MURO, J, POVEDA, A, BALANA, C

“…The aim of the study was to determine the dose-limiting toxicity and maximum tolerated dose of a first-line combination of doxorubicin and gemcitabine in adult…”
Get full text

Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020) by Mesia, R., Iglesias, L., Lambea, J., Martínez-Trufero, J., Soria, A., Taberna, M., Trigo, J., Chaves, M., García-Castaño, A., Cruz-Hernández, J. J.

“…A correction to this paper has been published: https://doi.org/10.1007/s12094-021-02582-0…”
Get full text

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1) by Mañós, M, Giralt, J, Rueda, A, Cabrera, J, Martinez-Trufero, J, Marruecos, J, Lopez-Pousa, A, Rodrigo, J.P, Castelo, B, Martínez-Galán, J, Arias, F, Chaves, M, Herranz, J.J, Arrazubi, V, Baste, N, Castro, A, Mesía, R

“…Highlights • Spanish Multidisciplinary consensus on squamus cell neoplasm os the head and neck. • Multidisciplinary approach for larynx/hypopharynx tumors. •…”
Get full text

SEOM Clinical Guideline of management of soft-tissue sarcoma (2016) by López-Pousa, A., Martin Broto, J., Martinez Trufero, J., Sevilla, I., Valverde, C., Alvarez, R., Carrasco Alvarez, J. A., Cruz Jurado, J., Hindi, N., Garcia del Muro, X.

“…Soft-tissue sarcomas are uncommon and heterogeneous tumors of mesenchymal origin. A soft-tissue mass that is increasing in size, greater than 5 cm, or located…”
Get full text

Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors by Bernad, I. Pajares, Trufero, J. Martínez, Urquizu, L. Calera, Pazo Cid, R. A., de Miguel, A. Cebollero, Agustin, M. J., Lanzuela, M., Antón, A.

“…Background Standard treatment for recurrent/metastatic head and neck squamous cell carcinoma (RM-SCCHN) is based in on platinum and cetuximab combination…”
Get full text

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study by Martin-Broto, J., Gutierrez, A., Garcia-del-Muro, X., Lopez-Guerrero, J.A., Martinez-Trufero, J., de Sande, L.M., Lainez, N., Maurel, J., De Juan, A., Losa, F., Andres, R., Casado, A., Tejido, P.G., Blanco, R., Carles, J., Bellmunt, J., Gomez-España, A., Ramos, R., Martinez-Serra, J., Llombart-Bosch, A., Poveda, A.

“…To assess whether deletions involving codons 557 and/or 558 (critical deletions) of exon 11 of KIT are relevant in the prognosis of relapse-free survival (RFS)…”
Get full text

Survival Differences of Patients with Resected Extraskeletal Osteosarcoma Receiving Two Different (Neo)Adjuvant Chemotherapy Regimens: A Systematic Review and Meta-analysis by Campos, F, Téres, R, Sebio, A, Bettim, B B, Martinez-Trufero, J

“…Extraskeletal osteosarcoma (ESOS) is a malignant tumour developing in soft tissues, characterised by the production of osteoid or bone matrix by tumour cells…”
Get full text

1624MO Weekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS) by Broto, J. Martin, Hindi, N., Redondo, A., Morales, J.M., Marcilla, D., Valverde, C., Luna, P., Diaz-Beveritge, R., Martinez-Trufero, J., Lopez-Martin, J.A., Martinez, V., Gutierrez, A., Lopez-Pousa, A.

Get full text

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS) by Mora, J, Castañeda, A, Perez-Jaume, S, Lopez-Pousa, A, Maradiegue, E, Valverde, C, Martin-Broto, J, Garcia del Muro, X, Cruz, O, Cruz, J, Martinez-Trufero, J, Maurel, J, Vaz, M A, de Alava, E, de Torres, C

“…Background: First Spanish trial of Ewing sarcoma (ES) including adults and children with the aim to test the efficacy of Gemcitabine and Docetaxel (G/D) in…”
Get full text

SEOM clinical guideline in nasopharynx cancer (2017) by Pastor, M., Lopez Pousa, A., del Barco, E., Perez Segura, P., Astorga, B. Gonzalez, Castelo, B., Bonfill, T., Martinez Trufero, J., Grau, J. Jose, Mesia, R.

“…Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to…”
Get full text

The importance of comorbidity assessment in patients with oral squamous cell carcinoma (OSCC): Could the adult comorbidity evaluation – 27 (ACE-27) provide an additional information? by Jariod Ferrer, U.M., Blanco Sanfrutos, S., Gavin Clavero, M.A., Uson Bouthelier, T., Nadal Cristobal, B., Moral Saez, I., Pajares Bernad, I., Cisneros Gimeno, A.I., Martinez Trufero, J.

Get full text

Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy by Hernando Cubero, J., Grande, E., Jimenez Fonseca, P., Villabona, C., Trigo Perez, J.M., Martinez Trufero, J., Pajares Bernad, I., Lopez, C., Alonso, T., Biarnes, J., RamónY Cajal, T., Duran, M., Grau, J.J., Arevalo Lobera, S., Mesia Nin, R., Llanos, M., Dalmau Portulas, E., Alvarez, C., Zafon, C., Capdevila, J.

Get full text